Ragaglitazar is a dual agonist of PPARα and PPARγ, exhibiting strong lipid-lowering and insulin-sensitizing properties. This compound has been shown to enhance glycemic control and improve lipid profiles in animal models of type 2 diabetes, making it a valuable tool for research in metabolic disorders and potential therapeutic applications in diabetes management.
Ragaglitazar is a dual agonist of PPARα and PPARγ, exhibiting strong lipid-lowering and insulin-sensitizing properties. This compound has been shown to enhance glycemic control and improve lipid profiles in animal models of type 2 diabetes, making it a valuable tool for research in metabolic disorders and potential therapeutic applications in diabetes management.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
